Basal and calcium-stimulated gastroesophageal sphincter pressure in patients with Zollinger-Ellison syndrome
- PMID: 858470
Basal and calcium-stimulated gastroesophageal sphincter pressure in patients with Zollinger-Ellison syndrome
Abstract
Basal lower esophageal sphincter (LES) pressure was measured in 6 patients with the Zollinger-Ellison syndrome (ZES) and hypergastrinemia, and in 6 patients with duodenal ulcer and normogastrinemia. Basal LES pressure in ZES patients, 17.0 +/- 3.7 (mean +/- SE) mm Hg was similar to basal LES pressure in duodenal ulcer patients, 18.3 +/- 3.5 mm Hg (P greater than 0.10). LES pressure and serum gastrin concentration were not related in the ZES patients, r = 0.03, or in the duodenal ulcer patients, r = 0.20. Intravenous infusion of calcium gluconate in ZES patients produced a marked rise in serum gastrin concentration, delta = 1580 +/- 1110 pg per ml (P less than 0.001), and a moderate but significant rise in LES pressure, delta = 5.9 +/- 0.9 mm Hg (P less than 0.05). In duodenal ulcer patients calcium infusion produced only slight rises in gastrin concentration, delta = 10 +/- 12 pg per ml, and LES pressure, delta = 2.1 +/- 0.5 mm Hg, which were not significant (P greater than 0.10). This study suggests that basal LES pressure is not regulated by blood gastrin levels in the ZES. We interpret the calcium infusion study to show that the LES pressure in patients with ZES may respond to acute changes in endogenous gastrin levels.
Similar articles
-
Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome.Gastroenterology. 1982 Jul;83(1 Pt 2):173-8. Gastroenterology. 1982. PMID: 6806138
-
Relationship between lower esophageal sphincter pressure and serum gastrin concentration in Zollinger-Ellison syndrome and other clinical settings.Gastroenterology. 1979 Jan;76(1):76-81. Gastroenterology. 1979. PMID: 758152 No abstract available.
-
Effect of somatostatin on lower esophageal sphincter (les) pressure and serum gastrin in normal and achalasic subjects.Horm Metab Res. 1982 Jan;14(1):26-8. doi: 10.1055/s-2007-1018911. Horm Metab Res. 1982. PMID: 6120888
-
Zollinger-Ellison syndrome: pathogenesis, diagnosis, and management.Am J Gastroenterol. 1997 Apr;92(4 Suppl):44S-48S; discussion 49S-50S. Am J Gastroenterol. 1997. PMID: 9127626 Review.
-
[Applications of radioimmunoassay to gastrin].Rev Clin Esp. 1975 Jan 31;136(2):97-110. Rev Clin Esp. 1975. PMID: 1091951 Review. Spanish. No abstract available.
Cited by
-
Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.Medicine (Baltimore). 2006 Nov;85(6):331-364. doi: 10.1097/MD.0b013e31802b518c. Medicine (Baltimore). 2006. PMID: 17108779 Free PMC article.
-
Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.Medicine (Baltimore). 2006 Nov;85(6):295-330. doi: 10.1097/01.md.0000236956.74128.76. Medicine (Baltimore). 2006. PMID: 17108778 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources